These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6587156)

  • 1. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
    Watabe S; Sendo F; Kimura S; Arai S
    J Natl Cancer Inst; 1984 Jun; 72(6):1365-70. PubMed ID: 6587156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of factor(s) that render polymorphonuclear leukocytes cytostatic from spleen cells stimulated with a streptococcal preparation, OK-432.
    Kimura S; Inoue T; Yamashita T; Midorikawa Y; Arai S; Sendo F
    Cancer Res; 1987 Dec; 47(23):6204-9. PubMed ID: 3315182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). I. Sequential effector mechanisms following a single OK-432 injection in F344 rats leading to the rejection of syngeneic MADB106 tumor cells.
    Fukui H; Reynolds CW
    J Natl Cancer Inst; 1987 Nov; 79(5):1011-7. PubMed ID: 3479632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H; Reynolds CW
    J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K; Kano S; Takaku F; Okumura K
    J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y; Torisu M
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of cytotoxic polymorphonuclear leukocytes by supernatant from a concanavalin A-stimulated spleen cell culture.
    Inoue T; Sendo F
    J Immunol; 1983 Nov; 131(5):2508-14. PubMed ID: 6605388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro lysis of target cells by rat polymorphonuclear leukocytes isolated from acute pyelonephritic exudates.
    Williams TW; Lyons JM; Braude AI
    J Immunol; 1977 Aug; 119(2):671-4. PubMed ID: 886190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor effect of lymphokine-activated rodent polymorphonuclear leukocytes.
    Fujii Y; Kimura S; Arai S; Sendo F
    Cancer Res; 1987 Nov; 47(22):6000-5. PubMed ID: 3117360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.
    Kato H; Inoue M; Yamamura Y; Tanigawa M; Sano H; Sugino S; Kondo M
    Nat Immun Cell Growth Regul; 1989; 8(5):290-300. PubMed ID: 2512482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
    Mizushima Y; Hirata H; Sakamoto K; Sato M; Morikage T; Maruyama M; Sasaki K; Yano S
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2710-5. PubMed ID: 3631971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.
    Morikawa K; Takeda R; Yamazaki M; Mizuno D
    Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differences in the immunostimulatory activity and antitumor therapeutic effect of OK-432 and N-CWS].
    Mizushima Y; Iwata M; Sato M; Hirata H; Takashima A; Yano S
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2404-10. PubMed ID: 3729493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A T cell leukemia line produces factor(s) that render rat neutrophils cytotoxic.
    Inoue T; Hamuro J; Yoshimoto R; Okano A; Shitara A; Arai S; Sendo F
    Jpn J Cancer Res; 1986 Jul; 77(7):693-702. PubMed ID: 3091556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of tumoricidal activity of OK-432-specific L3T4+ Lyt2- T-cells.
    Ozaki S; Suginoshita T; Watanabe T; Obayashi H
    Cancer Res; 1990 Aug; 50(15):4630-4. PubMed ID: 2369739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous intraperitoneal administration of OK-432 and serum enhances superoxide generation from migrated polymorphonuclear leukocytes, with special emphasis on the role of complements.
    Yoshikawa T; Takano H; Yoshida N; Kondo M
    Immunopharmacol Immunotoxicol; 1995 May; 17(2):265-82. PubMed ID: 7650290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human granulocyte colony-stimulating factor augments cytotoxicity of OK-432-induced polymorphonuclear leukocytes.
    Inoue M; Kato H; Mukai S; Kawahito Y; Asai K; Kimura S; Yamamura Y; Sano H; Sugino S; Kondo M
    Int J Immunopharmacol; 1994 Jan; 16(1):19-28. PubMed ID: 7512080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.